{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:49:03Z","timestamp":1761058143547,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":3000,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.rmed.2004.10.006","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T01:37:05Z","timestamp":1100741825000},"page":"648-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Delayed response to anti-tuberculosis treatment in a patient on infliximab"],"prefix":"10.1016","volume":"99","author":[{"given":"Elina","family":"Vlachaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Psathakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Tsintiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexios","family":"Iliopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2004.10.006_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00002281-200205000-00002","article-title":"Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases","volume":"14","author":"Criscione","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rmed.2004.10.006_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00002281-200307000-00005","article-title":"Biologic therapies in the spondyloarthritis","volume":"15","author":"Braun","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rmed.2004.10.006_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/keg263","article-title":"Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy","volume":"42","author":"Kroesen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rmed.2004.10.006_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00002281-200305000-00002","article-title":"Infectious complications of biologic treatments of rheumatoid arthritis","volume":"15","author":"Mohan","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rmed.2004.10.006_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2004.10.006_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1297-319X(02)00387-1","article-title":"Recommendations about the prevention and management of tuberculosis in patients taking infliximab","volume":"69","author":"Salmon","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.rmed.2004.10.006_bib7","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk","volume":"48","author":"Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rmed.2004.10.006_bib8","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.4049\/jimmunol.171.10.5579","article-title":"Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks","volume":"171","author":"Price","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.rmed.2004.10.006_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.rmed.2004.10.006_bib10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/rheumatology\/keg158","article-title":"Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy","volume":"42","author":"Taylor","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.rmed.2004.10.006_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/ard.61.3.207","article-title":"Repeated infusions of infliximab, a chimeric anti-TNF\u03b1 monoclonal antibody, in patients with active spondyloarthropathy","volume":"61","author":"Kruithof","year":"2002","journal-title":"Ann Rheum Dis"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611104003890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611104003890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:14:00Z","timestamp":1760609640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611104003890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0954611104003890"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2004.10.006","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed response to anti-tuberculosis treatment in a patient on infliximab","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2004.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}